Drug recall · February 19, 2014
Trelstar recall
Why: Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.
- Lots / codes
Lot #: 13J081, Exp 05/15
- Quantity
- 99 cartons
- Company
- Actavis Inc, Parsippany, NJ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- December 9, 2013 · Voluntary: Firm initiated
- Classified
- February 11, 2014
- Reported
- February 19, 2014
- Ended
- August 4, 2014
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.